Literature DB >> 17462499

Early activation markers of human peripheral dendritic cells.

Peter Hellman1, Håkan Eriksson.   

Abstract

Two major populations of dendritic cells (DCs), myeloid and plasmacytoid, can be isolated from human peripheral blood, and are distinguished by differential expression of the cell surface markers CD11c and CD123. These two populations of DCs also are different in their expression of Toll-like receptor (TLRs), which are involved in their activation. To investigate the early events during activation of peripheral DCs, the cells were stimulated in vitro with ligands for TLR-4 (as in lipopolysaccharides [LPS]) or TLR-9 (CpG-containing oligonucleotide [CpG]). The earliest change in protein expression detected after stimulating peripheral DCs with lipopolysaccharide (LPS) or CpG was increased production of the chemokine interleukin (IL)-8. Enhanced production of IL-8 occurred already within 2 hours of stimulation in both myeloid dendritic cells (M-DCs) and plasmacytoid dendritic cells (P-DCs), and preceded expression of the well established activation marker CD40. Although both populations of DCs secreted IL-8 upon activation, the levels of IL-8 produced was several times higher within the M-DCs compared with the P-DCs population. Before activation, both subsets of DCs expressed the IL-8 receptor type B (CD128b); but after stimulation the IL-8 receptor was down-regulated in both populations of DCs. Increased expression of MHC class II molecules is generally regarded as an early activation marker of DCs. However, only the P-DCs showed a significant up-regulation of MHC class II after stimulation. The M-DC population up-regulated MHC class II without any prior activation; thus care should be taken using increased expression of MHC class II molecules as an early activation marker of peripheral M-DCs after activation in vitro. In conclusion, we propose that during activation of human DCs the production of IL-8 and loss of CD128b are the earliest signs of activation preceding both MHC class II, CD40, CD80, and CD86 expression.

Entities:  

Mesh:

Substances:

Year:  2007        PMID: 17462499     DOI: 10.1016/j.humimm.2007.01.018

Source DB:  PubMed          Journal:  Hum Immunol        ISSN: 0198-8859            Impact factor:   2.850


  19 in total

1.  Toll-like receptor ligands synergize through distinct dendritic cell pathways to induce T cell responses: implications for vaccines.

Authors:  Qing Zhu; Colt Egelston; Aravindhan Vivekanandhan; Satoshi Uematsu; Shizuo Akira; Dennis M Klinman; Igor M Belyakov; Jay A Berzofsky
Journal:  Proc Natl Acad Sci U S A       Date:  2008-10-09       Impact factor: 11.205

Review 2.  Novel insights in preventing Gram-negative bacterial infection in cirrhotic patients: review on the effects of GM-CSF in maintaining homeostasis of the immune system.

Authors:  Dong Xu; Manzhi Zhao; Yuhu Song; Jianxin Song; Yuancheng Huang; Junshuai Wang
Journal:  Hepatol Int       Date:  2014-11-21       Impact factor: 6.047

3.  Induction of indoleamine 2,3-dioxygenase by Borrelia burgdorferi in human immune cells correlates with pathogenic potential.

Authors:  Andrea C Love; Ira Schwartz; Mary M Petzke
Journal:  J Leukoc Biol       Date:  2014-11-24       Impact factor: 4.962

4.  Immune adjuvant efficacy of CpG oligonucleotide in cancer treatment is founded specifically upon TLR9 function in plasmacytoid dendritic cells.

Authors:  Stefan Nierkens; Martijn H den Brok; Zacharias Garcia; Susan Togher; Jori Wagenaars; Melissa Wassink; Louis Boon; Theo J Ruers; Carl G Figdor; Stephen P Schoenberger; Gosse J Adema; Edith M Janssen
Journal:  Cancer Res       Date:  2011-07-25       Impact factor: 12.701

5.  Dual activation of Toll-like receptors 7 and 9 impairs the efficacy of antitumor vaccines in murine models of metastatic breast cancer.

Authors:  Mariela A Moreno Ayala; María Florencia Gottardo; María Soledad Gori; Alejandro Javier Nicola Candia; Carla Caruso; Andrea De Laurentiis; Mercedes Imsen; Slobodanka Klein; Elisa Bal de Kier Joffé; Gabriela Salamone; Maria G Castro; Adriana Seilicovich; Marianela Candolfi
Journal:  J Cancer Res Clin Oncol       Date:  2017-04-21       Impact factor: 4.553

6.  Acquired Protective Immunity in Atlantic Salmon Salmo salar against the Myxozoan Kudoa thyrsites Involves Induction of MHIIβ+ CD83+ Antigen-Presenting Cells.

Authors:  Laura M Braden; Karina J Rasmussen; Sara L Purcell; Lauren Ellis; Amelia Mahony; Steven Cho; Shona K Whyte; Simon R M Jones; Mark D Fast
Journal:  Infect Immun       Date:  2017-12-19       Impact factor: 3.441

7.  Human dendritic cell maturation and activation by a heat-killed recombinant yeast (Saccharomyces cerevisiae) vector encoding carcinoembryonic antigen.

Authors:  Cinzia Remondo; Vittore Cereda; Sven Mostböck; Helen Sabzevari; Alex Franzusoff; Jeffrey Schlom; Kwong-Y Tsang
Journal:  Vaccine       Date:  2008-12-25       Impact factor: 3.641

Review 8.  The role of CD40 and CD154/CD40L in dendritic cells.

Authors:  Daphne Y Ma; Edward A Clark
Journal:  Semin Immunol       Date:  2009-06-12       Impact factor: 11.130

9.  Paradoxical effects of all-trans-retinoic acid on lupus-like disease in the MRL/lpr mouse model.

Authors:  Xiaofeng Liao; Jingjing Ren; Cheng-Hsin Wei; A Catharine Ross; Thomas E Cecere; Bernard S Jortner; S Ansar Ahmed; Xin M Luo
Journal:  PLoS One       Date:  2015-03-16       Impact factor: 3.240

Review 10.  Dendritic cells, regulatory T cells and the pathogenesis of chronic hepatitis C.

Authors:  Phyllis T Losikoff; Alyssa A Self; Stephen H Gregory
Journal:  Virulence       Date:  2012-10-17       Impact factor: 5.882

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.